The MONY Group of New York announced last week that David Thomas, CEO of IMS Health, a market research firm for the pharmaceuticals and healthcare industries, has been nominated to MONY's board of directors. Shareholders will vote on the nomination at the firm's annual shareholder meeting scheduled for May 15.

"While [Thomas'] work in the healthcare, pharmaceutical and technology industries is valuable, it is his executive and management experience that will help us in addressing today's challenging business issues," said Michael Roth, CEO of The MONY Group.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.